Healthcare providers who use cloud computing feel safe with the practice, giving cloud computing a satisfaction score of 4.5 out of 5, according to KLAS.
Healthcare providers who use cloud computing feel safe with the practice, giving cloud computing a satisfaction score of 4.5 out of 5, according to a recent KLAS report.
But those holding out on the cloud are doing mainly because of the many remaining questions about the future of cloud computing in healthcare, according to the report “Cloud Computing Perception 2013: The Hybrid Cloud in Healthcare.”
Of the non-users, 66 percent said security was their main concern. They also listed uptime/reliability as a concern (38 percent), as well as loss of control (17 percent), cost (9 percent), and integration (2 percent), according to the report.
“The contrast in this report between cloud users and non-users is really telling,” Erik Westerlind, research director and report author, said in a release. “It really helps providers and vendors get a sense of the gaps that exist within current cloud offerings. Furthermore, providers will understand which vendors might be able to resolve their concerns.”
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.